TNF Pharmaceuticals (TNFA) Competitors $1.36 -0.11 (-7.48%) (As of 12/20/2024 05:23 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsTrends TNFA vs. TRIB, BMRA, VRAX, MYMD, NAVB, IDXX, LNTH, QDEL, NEOG, and CLDXShould you be buying TNF Pharmaceuticals stock or one of its competitors? The main competitors of TNF Pharmaceuticals include Trinity Biotech (TRIB), Biomerica (BMRA), Virax Biolabs Group (VRAX), MyMD Pharmaceuticals (MYMD), Navidea Biopharmaceuticals (NAVB), IDEXX Laboratories (IDXX), Lantheus (LNTH), QuidelOrtho (QDEL), Neogen (NEOG), and Celldex Therapeutics (CLDX). These companies are all part of the "diagnostic substances" industry. TNF Pharmaceuticals vs. Trinity Biotech Biomerica Virax Biolabs Group MyMD Pharmaceuticals Navidea Biopharmaceuticals IDEXX Laboratories Lantheus QuidelOrtho Neogen Celldex Therapeutics TNF Pharmaceuticals (NASDAQ:TNFA) and Trinity Biotech (NASDAQ:TRIB) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, community ranking, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk. Does the MarketBeat Community believe in TNFA or TRIB? Trinity Biotech received 335 more outperform votes than TNF Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformTNF PharmaceuticalsN/AN/ATrinity BiotechOutperform Votes33572.04% Underperform Votes13027.96% Which has stronger earnings and valuation, TNFA or TRIB? TNF Pharmaceuticals has higher earnings, but lower revenue than Trinity Biotech. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTNF PharmaceuticalsN/AN/A-$4MN/AN/ATrinity Biotech$59.13M0.10-$24.02M-$2.26-0.35 Does the media refer more to TNFA or TRIB? In the previous week, Trinity Biotech had 3 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 3 mentions for Trinity Biotech and 0 mentions for TNF Pharmaceuticals. Trinity Biotech's average media sentiment score of 0.36 beat TNF Pharmaceuticals' score of 0.00 indicating that Trinity Biotech is being referred to more favorably in the news media. Company Overall Sentiment TNF Pharmaceuticals Neutral Trinity Biotech Neutral Do insiders and institutionals believe in TNFA or TRIB? 9.6% of TNF Pharmaceuticals shares are held by institutional investors. Comparatively, 79.0% of Trinity Biotech shares are held by institutional investors. 1.2% of TNF Pharmaceuticals shares are held by company insiders. Comparatively, 8.2% of Trinity Biotech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is TNFA or TRIB more profitable? TNF Pharmaceuticals has a net margin of 0.00% compared to Trinity Biotech's net margin of -34.39%. Trinity Biotech's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets TNF PharmaceuticalsN/A -180.71% -84.27% Trinity Biotech -34.39%N/A -21.37% Which has more risk & volatility, TNFA or TRIB? TNF Pharmaceuticals has a beta of 2.12, indicating that its stock price is 112% more volatile than the S&P 500. Comparatively, Trinity Biotech has a beta of 0.97, indicating that its stock price is 3% less volatile than the S&P 500. SummaryTrinity Biotech beats TNF Pharmaceuticals on 8 of the 11 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get TNF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNFA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNFA vs. The Competition Export to ExcelMetricTNF PharmaceuticalsDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.75M$2.51B$5.14B$9.08BDividend YieldN/A0.73%5.09%4.23%P/E RatioN/A6.0790.0517.19Price / SalesN/A75.121,116.25117.05Price / CashN/A15.0543.1037.85Price / Book0.193.284.784.78Net Income-$4M$29.98M$120.31M$225.60M7 Day Performance18.26%-1.55%-1.92%-1.23%1 Month Performance1.49%6.18%13.65%0.46%1 Year PerformanceN/A-20.93%28.34%15.24% TNF Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNFATNF PharmaceuticalsN/A$1.36-7.5%N/AN/A$3.75MN/A0.006Gap DownTRIBTrinity Biotech1.2087 of 5 stars$0.89-1.7%N/A-64.5%$6.78M$56.83M-0.39480News CoveragePositive NewsGap DownBMRABiomerica0.1423 of 5 stars$0.31-2.0%N/A-76.8%$5.17M$5.51M-0.8260Gap DownVRAXVirax Biolabs Group0.6841 of 5 stars$1.52-3.2%N/A+25.0%$4.91M$84,872.000.005News CoverageMYMDMyMD PharmaceuticalsN/A$1.15-3.4%N/A-80.1%$2.73MN/A0.009NAVBNavidea BiopharmaceuticalsN/A$0.00flatN/A-99.8%$10,000.00$8,126.000.0010Analyst ForecastIDXXIDEXX Laboratories4.9734 of 5 stars$433.51+0.3%$539.63+24.5%-25.4%$35.50B$3.84B41.6711,000Positive NewsLNTHLantheus4.3826 of 5 stars$94.38+1.5%$130.00+37.7%+50.4%$6.56B$1.50B15.42834Analyst ForecastQDELQuidelOrtho4.1197 of 5 stars$43.00+4.0%$53.43+24.3%-39.2%$2.89B$3.00B-1.577,100Positive NewsNEOGNeogen3.4918 of 5 stars$12.05-0.8%$17.50+45.2%-41.8%$2.61B$912.20M-110.452,640Analyst ForecastNews CoverageCLDXCelldex Therapeutics2.6408 of 5 stars$26.26+3.3%$62.25+137.1%-33.5%$1.74B$6.88M-9.89160Analyst ForecastNews Coverage Related Companies and Tools Related Companies Trinity Biotech Alternatives Biomerica Alternatives Virax Biolabs Group Alternatives MyMD Pharmaceuticals Alternatives Navidea Biopharmaceuticals Alternatives IDEXX Laboratories Alternatives Lantheus Alternatives QuidelOrtho Alternatives Neogen Alternatives Celldex Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TNFA) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TNF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TNF Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TNFA Stock Alerts